ABSI vs HSIC · rev $533.0K vs P/E 24, rev $6.83B
Absci Corp (ABSI) versus Henry Schein Inc (HSIC) — a side-by-side from cached financials, not a winner call.
Absci Corp (ABSI) is a biotechnology company listed on NASDAQ.
Henry Schein Inc (HSIC) is a medical distribution company listed on NASDAQ.
Latest reported ABSI revenue for 2026-06-30 was $533.0K. Net income was -$62.8M. ABSI currently screens at market cap $1.13B.
Latest reported HSIC revenue for 2026-06-27 was $6.83B. Net income was $201.0M. HSIC currently screens at market cap $9.11B and trailing P/E 24.2.
ABSI currently screens at market cap $1.13B. HSIC currently screens at market cap $9.11B and trailing P/E 24.2.
Not investment advice. Open the ABSI and HSIC stock pages for the full models.
Not investment advice.